RTK signaling inhibitors

RTK signaling inhibitors are medications designed to block receptor tyrosine kinases (RTKs), which are proteins on cell surfaces that transmit signals promoting cell growth and division. When these signals become overactive, they can lead to uncontrolled cell growth, such as in cancers. RTK inhibitors prevent these signals from being sent or received, thereby slowing or halting tumor growth. They are used to treat certain cancers by targeting specific RTKs involved in disease progression, offering a precise approach to interrupt abnormal cell signaling pathways.